Drug Shortage Report for PAMIDRONATE DISODIUM FOR INJECTION

Last updated on 2020-07-14 History
Report ID 114915
Drug Identification Number 02244550
Brand name PAMIDRONATE DISODIUM FOR INJECTION
Common or Proper name Pamidronate Disodium for Injection
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) PAMIDRONATE DISODIUM
Strength(s) 3MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 x 10mL
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-06-16
Estimated end date
Actual end date 2020-07-13
Shortage status Resolved
Updated date 2020-07-14
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-07-14 English Compare
v9 2020-07-13 French Compare
v8 2020-07-13 English Compare
v7 2020-07-07 French Compare
v6 2020-07-07 English Compare
v5 2020-06-17 English Compare
v4 2020-06-16 French Compare
v3 2020-06-16 English Compare
v2 2020-05-13 French Compare
v1 2020-05-13 English Compare